Topical oropharyngeal vancomycin to control methicillin-resistant Staphylococcus aureus lower airway infection in ventilated patients

Minerva Anestesiologica

Volumn 76, Issue 3, 2010, Pages 193-202

  Silvestri, L ^a   Solidoro, A ^b   Milanese, M ^a   Van Saene, H K F ^c   Fontana, F ^b   Gregori, D ^d   Gullo, A ^e  

^a Ospedale Civile di Gorizia   (Italy)

^b Hospital of Monfalcone   (Italy)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

Author keywords

Methicillin resistant staphylococcus aureus; Vancomycin; Ventilation

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OBSERVATIONAL STUDY; OROPHARYNX; PROSPECTIVE STUDY; RISK FACTOR;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; ENDPOINT DETERMINATION; FEMALE; HUMANS; INTENSIVE CARE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OROPHARYNX; RESPIRATION, ARTIFICIAL; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN; YOUNG ADULT;

EID: 77749273656     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Loveday HP, Pellowe CM, Jones SR, Pratt RJ. A systematic review of the evidence for interventions for the prevention and control of methicillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). J Hosp Infect 2006;63(Suppl 1):S45-S70.
2. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009;2360-8.
3. Shorr AF, Combes A, Kollef MH, Chastre J. Methicillinresistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 2006;34: 700-6.
4. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006;10:R97.
5. Athanassa Z, Siempos II, Falagas ME. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J 2008;31:625-32.
6. Coello R, Jimenez J, Garcia M, Arroyo P, Minguez D, Fernández C et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994;13:74-81.
7. Shahin R, Johnson IL, Jamieson E, McGeer A, Tolkin J, Ford-Jones EL. Methicillin resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med 1999;153:864-8.
8. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus outbreaks. Antimicrob Agents Chemother 1999;43:1412-6.
9. Silvestri L, Milanese M, Oblach L, Fontana F, Gregori D, Guerra R et al. Enteral vancomycin to control methicillin resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002;30:391-9.
10. de la Cal MA, Cerdà E, van Saene HKF, Garcia-Hierro P, Negro E, Parra ML et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 2004;56:175-83.
11. Silvestri L, van Saene HKF, Milanese M, Fontana F, Gregori D, Oblach L et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomized trial. Eur Respir J 2004;23:921-6.
12. Sanchez M, Mir N, Canton R, Luque R, Lopez B, Baquero F. The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphylococcus aureus in critically ill patients. A double-blind, randomized, placebo-controlled study. (abstract 119) in Programme and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1997. p. 310.
13. Cerda E, Abella A, de la Cal MA, Lorente JA, Garcia-Hierro P, van Saene HKF et al. Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit. Ann Surg 2007;245:397-407.
14. Viviani M, van Saene HKF, Dezzoni R, Silvestri L, Di Lenarda R, Berlot G et al. Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care 2005;33:361-72.
15. Thornburn K, Taylor N, Saladi SM, van Saene HKF. Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in paediatric intensive care unit. Clin Microbiol Infect 2006;12:35-42.
16. Wenzel RP, Reagan DR, Bertino JS, Baron EJ, Arias K. Methicillin- resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines. Am J Infect Control 1998;26:102-10.
17. van Saene HKF, Petros AJ, Ramsay G, Baxby D. All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Medicine 2003;29:677-90.
18. Ewig S, Torres A, El-Elbiary M, Fabregas N, Hernandez C, Gonzalez J et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 1999;159: 188-98.
19. Bonten MJM. Selective digestive tract decontamination -will it prevent infection with multidrug-resistant Gram-negative pathogens but still be applicable in institutions where methicillin-resistant enterococci are endemic? Clin Infect Dis 2006;42:570-4.
20. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PMM, Vroom MB, Dankert J. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003;362:1011-6.
21. Krueger WA, Lenhart F-P, Neeser G, Ruckdeschel G, Schreckhase H, Eissner H-J et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients. A prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 2002;166:1029-37.
22. de Smet AMGA, Kluytmans JAJW, Cooper BS, Mascini EM, Benus RFJ, van der Werf TS et al. Decontamination of the digestive tract and oropharynx in ICU patients. New Engl J Med 2009;360:20-31.
23. Silvestri L, van Saene HKF. Selective decontamination of the digestive tract does not increase resistance in critically ill patients: evidence from randomized controlled trials. Critical Care Med 2006;34:2027-9.
24. Bergmans DCJJ, Bonten MJM, Gaillard CA, Paling JC, van der Geest S, van Tiel FH et al. Prevention of ventilator-associated pneumonia by oral decontamination. A prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001;164:382-8.
25. Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Critical Care Med 1993;21:1466-73.
26. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA 1991;265:2704-10.
27. Gaussorgues PH, Salord F, Sirodot M, Tigaud S, Cagnin S, Gerard M et al. Efficacité de la decontamination digestive sur la survenue des bacteriemies nosocomiales chez les patients sous ventilation mecanique et recevant des betamimetiques. Rean Soins Intens Med Urg 1991;7:169-74.
28. Schardey HM, Joosten U, Finke U, Staubach KH, Schauer R, Heiss A et al. The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled, multicenter trial. Ann Surg1997;225:172-80.
29. Arnow PA, Caradang GC, Zabner R, Irwin ME. Randomized controlled trial of selective decontamination for prevention of infections following liver transplantation. Clin Infect Dis 1996;22:997-1003.
30. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV et al. A randomized, prospective, double blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002;73:1904-9.
31. Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Critical Care Med 2002:30:1204-9.
32. Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999;115:1085-91.
33. Gastinne H, Wolff M, Lacharte G, Boiteau R, Savy FP. Antibiotic levels in bronchial tree and in serum during selective digestive decontamination. Intensive Care Med 1991;17:215-8.
34. Fagon J-Y, Chastre J, Rouby J-J. Is bronchoalveolar lavage with quantitative cultures a useful tool for diagnosis ventilator-associated pneumonia? Crit Care 2007;11:123.
35. Valencia M, Torres A. Ventilator-associated pneumonia. Curr Opin Crit Care 2009;15:30-5.
36. Canadian Critical Care Trials Group: A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355:2619-30.
37. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, El-Ebiary M, Carrillo A, Ruiz J et al. Impact of invasive and non invasive quantitative culture sampling on outcome of ventilatorassociated pneumonia: a pilot study. Am J Respir Crit Care Med 1998;157:371-6.
38. Ruiz M, Torres A, Ewig S, Marcos MA, Alcon A, Uedo R et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000;162:119-25.
39. Sole Violan J, Fernandez JA, Benitez AB, Cardenosa Cendrero JA, Rodriguez de Castro F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000;28:2737-41.
40. Lampati L, Maggioni E, Langer M, Malacarne P, Mozzo R, Pesenti A et al. Can routine surveillance samples from tracheal aspirate predict bacterial flora in cases of ventilatorassociated pneumonia? Minerva Anestesiol 2009;75:555-62.
41. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 1993;307:525-32.
42. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-13.
43. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. 16th information supplement, M100-S16. Wayne, PA: Clinical and Laboratory Standard Institute; 2006.